BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. DNMT1, T cell receptor signaling pathway, Leukemia, Hypothalamus, Autoimmunity)
Bookmark Forward

QuickView for miR-133 (gene)


Body Atlas

Most Correlated Tissues

No tissues found
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. No diseases found
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. No compounds found
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. No perturbed genes found
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Cap binding in Drosophila female late embryonic cell line Kc167 by ChIP-chip (modENCODE)
  2. HP1a binding (HP1a hinge antibody) in S2-DRSC late embryonic male cells by ChIP-chip (modENCODE)
  3. Insulator-associated protein binding sites in Drosophila embryos at 0-12hr by ChIP-chip (modENCODE)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. MiR-23b and miR-133 Cotarget TGFβ2/NOTCH1 in Sheep Dermal Fibroblasts, Affecting Hair Follicle Devel…
  2. Endurance training changes the expression of miR-1 and miR-133 and predicted genes in slow and fast …
  3. MicroRNA-133 suppresses cell viability and migration of rheumatoid arthritis fibroblast-like synovio…
  4. Expression and clinical significance of miR-1 and miR-133 in pre-diabetes.
  5. MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Interest of Plasma microRNAs
  2. Probiotics on Body Composition and Insulin Resistance in Patients With Obesity and Its Association W…
  3. Roles of microRNAs in the Development of Osteoporosis in Men - Preliminary Study
  4. miRNA and Myokines in Patients With PAH
  5. Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.